Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Makoto, Nishino"'
Autor:
Takaaki Itonaga, Noriyuki Yanagida, Ken-ichi Nagakura, Tomoyuki Asaumi, Mai Tokunaga, Makoto Nishino, Kyohei Takahashi, Kiyotake Ogura, Sakura Sato, Motohiro Ebisawa
Publikováno v:
Allergology International, Vol 73, Iss 3, Pp 416-421 (2024)
Background: Low-dose oral food challenge (LD-OFC) is an approach to avoid complete elimination in high-risk patients with wheat allergy (WA). We examined the 3-year prognosis after LD-OFC among patients who passed and failed LD-OFC. Methods: Children
Externí odkaz:
https://doaj.org/article/3908dd5fb2c2472ca1debe13ec0a1a50
Autor:
Taichi Igarashi, Marianne Mazevet, Takaaki Yasuhara, Kimiyoshi Yano, Akifumi Mochizuki, Makoto Nishino, Tatsuya Yoshida, Yukihiro Yoshida, Nobuhiko Takamatsu, Akihide Yoshimi, Kouya Shiraishi, Hidehito Horinouchi, Takashi Kohno, Ryuji Hamamoto, Jun Adachi, Lee Zou, Bunsyo Shiotani
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-22 (2023)
Abstract Activation of the KRAS oncogene is a source of replication stress, but how this stress is generated and how it is tolerated by cancer cells remain poorly understood. Here we show that induction of KRASG12V expression in untransformed cells t
Externí odkaz:
https://doaj.org/article/43f90e5e10dd446096f58be5f96dcc74
Autor:
Shuhei Hara, MD, Takaaki Itonaga, MD, Makoto Nishino, MD, Noriyuki Yanagida, MD, PhD, Sakura Sato, MD, Motohiro Ebisawa, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 2, Pp 100096- (2023)
This case series study is the first report of Japanese adolescents who experienced dupilumab facial redness after starting dupilumab treatment for refractory atopic dermatitis. In every case, dupilumab facial redness subsided without discontinuation
Externí odkaz:
https://doaj.org/article/6b89bc01ccae48a389d496feacd08047
Autor:
Makoto Nishino, Maiko Fujimori, Takafumi Koyama, Makoto Hirata, Noriko Tanabe, Toshio Shimizu, Noboru Yamamoto, Yosuke Uchitomi
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0283968 (2023)
Precision medicine is rapidly changing the diagnostic and treatment spectrum of oncology. In May 2019, comprehensive genomic profiling (CGP) (somatic and/or germline) was approved for reimbursement in Japan. While the promise of novel and targeted th
Externí odkaz:
https://doaj.org/article/ea3900362ae049a4aec01f52771fe6e2
Autor:
Naoko Fusayasu, Tomoyuki Asaumi, Kyohei Takahashi, Ken-ichi Nagakura, Makoto Nishino, Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa
Publikováno v:
Allergology International, Vol 71, Iss 2, Pp 248-250 (2022)
Externí odkaz:
https://doaj.org/article/71505236f9f4473c82a372df409810e0
Autor:
Naoki Furuya, Makoto Nishino, Kazushige Wakuda, Satoshi Ikeda, Takashi Sato, Ryota Ushio, Shigeru Tanzawa, Masafumi Sata, Kentaro Ito
Publikováno v:
Thoracic Cancer, Vol 12, Iss 5, Pp 613-618 (2021)
Abstract Background Atezolizumab is a programmed death‐ligand 1 (PD‐L1) targeted monoclonal antibody that inhibits PD‐L1 interacting with its receptors PD‐1 and B7‐1, thereby enhancing anticancer immunity. Some real‐world efficacy and saf
Externí odkaz:
https://doaj.org/article/96a8ca820c444f5d81bd08a6dca53ff2
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100410- (2020)
Externí odkaz:
https://doaj.org/article/ceb637d8629b43aab38ba76f814fb3b0
Autor:
Ken-ichi Nagakura, Noriyuki Yanagida, Makoto Nishino, Kyohei Takahashi, Sakura Sato, Motohiro Ebisawa
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100420- (2020)
Externí odkaz:
https://doaj.org/article/8994ff46b27d4d2eab9c66d0af44c62d
Autor:
Sakura Sato, Noriyuki Yanagida, Kazuko Kutsuwada, Naoko Fusayasu, Ken-ichi Nagakura, Makoto Nishino, Chizuko Sugizaki, Motohiro Ebisawa
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100421- (2020)
Externí odkaz:
https://doaj.org/article/b40b41279e584999bb934bca7c9c90e5
Autor:
Satoru Iwasa, Takafumi Koyama, Makoto Nishino, Shunsuke Kondo, Kazuki Sudo, Kan Yonemori, Tatsuya Yoshida, Kenji Tamura, Toshio Shimizu, Yutaka Fujiwara, Shigehisa Kitano, Akihiko Shimomura, Jun Sato, Fumiharu Yokoyama, Hiroyuki Iida, Maki Kondo, Noboru Yamamoto
Publikováno v:
Cancer Science. 114:211-220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1808e1902d7c67fb5a81c2b1d201948
https://doi.org/10.1111/cas.15574
https://doi.org/10.1111/cas.15574